264 related articles for article (PubMed ID: 34058036)
1. An open-label non-inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma.
Ray A; Manikanta J; Singh K; Gabra P; Vyas S; Singh G; Xess I; Sethi P; Meena VP; Soneja M; Sinha S; Wig N; Kabra SK
Mycoses; 2021 Sep; 64(9):1038-1044. PubMed ID: 34058036
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of nebulised amphotericin B deoxycholate (Fungizone
Otu AA; Langridge P; Denning DW
Mycoses; 2019 Nov; 62(11):1049-1055. PubMed ID: 31479538
[TBL] [Abstract][Full Text] [Related]
3. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
Purcell IF; Corris PA
Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
[TBL] [Abstract][Full Text] [Related]
4. Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.
Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Min WS; Shin WS
Korean J Intern Med; 2006 Sep; 21(3):165-72. PubMed ID: 17017665
[TBL] [Abstract][Full Text] [Related]
5. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K;
Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454
[TBL] [Abstract][Full Text] [Related]
6. Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
Yoshida I; Saito AM; Tanaka S; Choi I; Hidaka M; Miyata Y; Inoue Y; Yamasaki S; Kagoo T; Iida H; Niimi H; Komeno T; Yoshida C; Tajima F; Yamamoto H; Takase K; Ueno H; Shimomura T; Sakai T; Nakashima Y; Yoshida C; Kubonishi S; Sunami K; Yoshida S; Sakurai A; Kaneko Y; Miyazaki Y; Nagai H
Mycoses; 2020 Aug; 63(8):794-801. PubMed ID: 32391919
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
Agarwal R; Vishwanath G; Aggarwal AN; Garg M; Gupta D; Chakrabarti A
Mycoses; 2013 Sep; 56(5):559-70. PubMed ID: 23496375
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pulmonary aspergilloma. Clinical review].
Martínez J; Márquez M; Sola O; Arés J; Grarau J
Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):413-5. PubMed ID: 11153205
[No Abstract] [Full Text] [Related]
9. Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial.
Saito AM; Yoshida I; Tanaka S; Sawamura M; Hidaka M; Yoshida S; Uike N; Kaneko Y; Miyazaki Y; Nagai H
Kurume Med J; 2021 Dec; 66(4):239-246. PubMed ID: 34544939
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
11. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma.
Kravitz JN; Berry MW; Schabel SI; Judson MA
Chest; 2013 May; 143(5):1414-1421. PubMed ID: 23117277
[TBL] [Abstract][Full Text] [Related]
12. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
Chishimba L; Langridge P; Powell G; Niven RM; Denning DW
J Asthma; 2015 Apr; 52(3):289-95. PubMed ID: 25158109
[TBL] [Abstract][Full Text] [Related]
14. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
Caillot D
Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pulmonary aspergilloma in cystic fibrosis by percutaneous instillation of amphotericin B via indwelling catheter.
Ryan PJ; Stableforth DE; Reynolds J; Muhdi KM
Thorax; 1995 Jul; 50(7):809-10. PubMed ID: 7570423
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of 61 patients with pulmonary aspergilloma.
Kawamura S; Maesaki S; Tomono K; Tashiro T; Kohno S
Intern Med; 2000 Mar; 39(3):209-12. PubMed ID: 10772121
[TBL] [Abstract][Full Text] [Related]
17. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Godet C; Couturaud F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Bourdin A; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Bergeron A; Gondouin A; Frat JP; Flament T; Camara B; Priou P; Brun AL; Laurent F; Ragot S; Cadranel J; ; Godet C; Couturaud F; Cadranel J; Frat JP; Brun AL; Laurent F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Gondouin A; Flament T; Camara B; Priou P; Ragot S
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764182
[TBL] [Abstract][Full Text] [Related]
18. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
19. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
Fujita M; Tao Y; Kajiki A; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
J Infect Chemother; 2012 Oct; 18(5):668-74. PubMed ID: 22350405
[TBL] [Abstract][Full Text] [Related]
20. Antifungal treatment and chronic rhinosinusitis.
Lal D; Stankiewicz JA
Curr Allergy Asthma Rep; 2009 May; 9(3):227-31. PubMed ID: 19348723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
